Tizanidine 51655-0740
Product NDC
51655-0740- Manufacturer
- Northwind Health Company, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 23, 2022
- Listing Expires
- December 31, 2027
- Application
- ANDA076416
Need to source Tizanidine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tizanidine Hydrochloride | 4 mg/1 |
Drug Class
Adrenergic alpha2-Agonists [MoA]Central alpha-2 Adrenergic Agonist [EPC]
Packaging Options(3)
90 TABLET in 1 BOTTLE, PLASTIC (51655-740-26)
30 TABLET in 1 BOTTLE, PLASTIC (51655-740-52)
15 TABLET in 1 BOTTLE, PLASTIC (51655-740-54)